All News #Library
Biotech
Viracta Therapeutic Closes NAVAL-1 Trial, Explores Strategic Option
26 Dec 2024 //
GLOBENEWSWIRE
Viracta Therapeutics Reprioritizes on Nana-Val for EBV+Lymphoma
06 Nov 2024 //
GLOBENEWSWIRE
Viracta Announces Positive Data From Phase 2 Trial And Regulatory Progress
14 Aug 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support